Harmony Biosciences Holdings (HRMY) Interest Coverage Ratio (2019 - 2026)
Harmony Biosciences Holdings (HRMY) posted Interest Coverage Ratio of 11.22 for Q1 2026, up 4.22% sequentially from 10.76 in Q4 2025, and up 256.7% YoY from 3.15 in Q1 2025.
Harmony Biosciences Holdings (HRMY) Interest Coverage Ratio (2019 - 2026) Analysis & Trends
Harmony Biosciences Holdings has reported Interest Coverage Ratio for 8 years, with the latest figure at 11.22 in Q1 2026.
- Quarterly Interest Coverage Ratio rose 256.7% year-over-year to 11.22 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 9.86 (down 9.59% YoY) and the FY2025 annual result came in at 4.01, down 7.99% from the prior year.
- Interest Coverage Ratio rose to 11.22 in Q1 2026 per HRMY's latest filing, from 10.76 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 13.24 in Q4 2024 and troughed at 0.5 in Q3 2022.
- A 5-year average of 4.01 and a median of 2.18 in 2024 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2023 and 2024: Interest Coverage Ratio jumped 442.05% in 2023, then slumped 68.66% in 2024.
- Over 5 years, Interest Coverage Ratio stood at 6.38 in 2022, then dropped by 22.28% to 4.96 in 2023, then soared by 166.93% to 13.24 in 2024, then declined by 18.7% to 10.76 in 2025, then climbed by 4.22% to 11.22 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 11.22, 10.76, and 3.66 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Harmony Biosciences Holdings | 2.22 Bn | 1.41 Bn | 198.08 Mn | 1.85 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.85 |
| Mar 31, 2026 | 11.22 |
| Dec 31, 2025 | 10.76 |
| Sep 30, 2025 | 3.66 |
| Jun 30, 2025 | 1.62 |
| Mar 31, 2025 | 3.15 |
| Dec 31, 2024 | 13.24 |
| Sep 30, 2024 | 0.85 |
| Jun 30, 2024 | 0.77 |
| Mar 31, 2024 | 2.18 |
| Dec 31, 2023 | 4.96 |
| Sep 30, 2023 | 2.71 |
| Jun 30, 2023 | 1.97 |
| Mar 31, 2023 | 1.70 |
| Dec 31, 2022 | 6.38 |
| Sep 30, 2022 | 0.50 |
| Jun 30, 2022 | 1.39 |
| Mar 31, 2022 | 1.16 |
| Dec 31, 2021 | 7.47 |
| Sep 30, 2021 | 1.13 |